comparemela.com
Home
Live Updates
Duchenne Muscular Dystrophy Drugs Market - Breaking News
Pages:
Latest Breaking News On - Duchenne muscular dystrophy drugs market - Page 1 : comparemela.com
Global Duchenne Muscular Dystrophy Drugs Market Set to
Dublin, April 29, 2024 (GLOBE NEWSWIRE) The
United states
Asia pacific
Santhera pharmaceuticals
Ns pharma inc
Therapeutics inc
Fibrogen inc
Sarepta therapeutics inc
Nippon shinyaku co
Duchenne muscular dystrophy drugs market
Product type
Therapeutic approach
End user
North america
Latin america
Middle east
Market value
Duchenne Muscular Dystrophy Drugs Global Market Report 2023: Sector to Reach $18 1 Billion by 2030 at a 42 5% CAGR
/PRNewswire/ The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to ResearchAndMarkets.com s offering. Global.
Volgogradskaya oblast
Eli lilly
Laura wood
Office hours call
Biomarin pharmaceutical inc
Nippon shokubai co ltd
E st office hours call
Janssen pharmaceuticals inc
Bristol myers squibb company
Akashi therapeutics inc
Research platform
Taiho pharmaceutical co ltd
Nobelpharma co ltd
Pfizer inc
Acceleron pharma inc
Lexicon pharmaceuticals inc
Global Duchenne Muscular Dystrophy Drugs Business Report
Dublin, Jan. 26, 2023 (GLOBE NEWSWIRE) The "Duchenne Muscular Dystrophy Drugs - Global Strategic Business Report" report has been added to .
Volgogradskaya oblast
Eli lilly
Nippon shokubai co ltd
Taiho pharmaceutical co ltd
Janssen pharmaceuticals inc
Biomarin pharmaceutical inc
Bristol myers squibb company
Lexicon pharmaceuticals inc
Akashi therapeutics inc
Pfizer inc
Therapeutics inc
Nobelpharma co ltd
Sarepta therapeutics inc
Research platform
Acceleron pharma inc
Muscular dystrophy drugs
vimarsana © 2020. All Rights Reserved.